Cancer Immunology, Immunotherapy

, Volume 59, Issue 5, pp 799–803

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3

  • Cornelia L. Trimble
  • Shiwen Peng
  • Christopher Thoburn
  • Ferdynand Kos
  • T. C. Wu
Short Communication

DOI: 10.1007/s00262-009-0806-4

Cite this article as:
Trimble, C.L., Peng, S., Thoburn, C. et al. Cancer Immunol Immunother (2010) 59: 799. doi:10.1007/s00262-009-0806-4
  • 134 Downloads

Abstract

Essentially all squamous cervical cancers and their precursor lesions, high grade cervical intraepithelial neoplasia (CIN2/3), are caused by persistent human papillomavirus (HPV) infection. However, not all CIN2/3 lesions progress to cancer. In a brief, observational study window monitoring subjects with CIN2/3 from protocol entry (biopsy diagnosis) to definitive therapy (cervical conization) at week 15, in a cohort of 50 subjects, we found that 26% of CIN2/3 lesions associated with HPV16, the genotype most commonly associated with disease, underwent complete histologic regression. Nonetheless, HPV16-specific T cell responses measured in peripheral blood obtained at the time of study entry and at the time of conization were marginally detectable directly ex vivo, and did not correlate with lesion regression. This finding suggests that, in the setting of natural infection, immune responses which are involved in elimination of cervical dysplastic epithelium are not represented to any great extent in the systemic circulation.

Keywords

Human papillomavirus (HPV)Cervical dysplasiaRegressionSystemic immune response

Abbreviations

HPV

Human papillomavirus

CIN

Cervical intraepithelial neoplasia

SCC

Squamous cervical cancer

PBMC

Peripheral blood mononuclear cells

ELISPOT

Enzyme-linked immunosorbent spot assay

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Cornelia L. Trimble
    • 1
  • Shiwen Peng
    • 3
  • Christopher Thoburn
    • 2
  • Ferdynand Kos
    • 2
  • T. C. Wu
    • 3
  1. 1.Department of Gynecology and ObstetricsJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of OncologyJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of PathologyJohns Hopkins University School of MedicineBaltimoreUSA